Stimulation of local immunity and protection in mice by intramuscular immunization with triple- or double-layered rotavirus particles and QS-21

Virology

Volumn 243, Issue 1, 1998, Pages 158-166

  McNeal, Monica M ^a   Rae, Mary N ^a   Conner, Margaret E ^b   Ward, Richard L ^a  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADJUVANT; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; NEUTRALIZING ANTIBODY; QS 21;

ADOLESCENT; ANIMAL MODEL; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; FECES; FEMALE; IMMUNE RESPONSE; IMMUNITY; IMMUNIZATION; INTRAMUSCULAR DRUG ADMINISTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; ROTAVIRUS; VIRUS INFECTION; VIRUS PARTICLE; VIRUS SHEDDING;

ANIMALIA; MURINAE; MURINE ROTAVIRUS; RNA VIRUSES; ROTAVIRUS;

EID: 0032579776     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1998.9060     Document Type: Article

References (40)

1. Ahmeida E. T. S. B., Jennings R., Erturk M., Potter C. W. The IgA and subclass IgG responses and protection in mice immunized with influenza antigens administered as ISCOMS, with FCA, ALH or an infectious virus. Arch. Virol. 125:1992;71-86.
2. Ahmeida E. T. S. B., Gregoriadis G., Potter C. W., Jennings R. Immunopotentiation of local and systemic humoral immune responses by ISCOMs, liposomes and FCA: Role in protection against influenza A in mice. Vaccine. 11:1993;1302-1309.
3. Bernstein D. I., Sander D. S., Smith V. E., Schiff G. M., Ward R. L. Protection from rotavirus reinfection: Two-year prospective study. J. Infect. Dis. 164:1991;277-283.
4. Bernstein D. I., Glass R. I., Rodgers G., Sack D. A. Evaluation of rhesus rotavirus monovalent and tetravalent reassortant vaccines in U. S. children. J. Am. Med. Assoc. 273:1995;1191-1221.
5. Bomford R., Stapleton M., Winsor S., McKnight A., Andronova T. The control of the antibody isotype response to recombinant human immunodeficiency virus gp120 antigen by adjuvants. AIDS Res. Hum. Retrovirus. 8:1992;1765-1771.
6. Burns J. W., Siadat-Pajouh M., Krishnaney A. A., Greenberg H. B. Protective effect of rotavirus VP6-specific IgA monoclonal antibodies that lack neutralizing activity. Science. 272:1996;104-107.
7. Christy C., Madore H. P., Pichichero M. E., Gala C., Pincus P., Vosefski D., Hoshino Y., Kapikian A., Dolin R. Field trial of rhesus rotavirus vaccine in infants. Pediatr. Infect. Dis. J. 7:1988;645-650.
8. Clark H. F., White C. J., Offit P. A., Stinson D., Eiden J., Weaver S., Cho I., Shaw A., Krah D., Ellis R. Preliminary evaluation of safety and efficacy of quadrivalent human-bovine reassortant rotavirus vaccine (QHBRV). Pediatr Res. 37:1995.
9. Conner M. E., Crawford S. E., Barone C., Estes M. K. Rotavirus vaccine administered parenterally induces protective immunity. J. Virol. 67:1993;6633-6641.
10. DeMol P., Zissis G., Butzler J. P., Mutwewingabo A., Andre F. E. Failure of live, attenuated oral rotavirus vaccine. Lancet. ii:1986.
11. Estes, M. K. 1996, Rotaviruses and their replication, In, Fields Virology, 2, 1625, 1655, Raven Publishers, Philadelphia, PA.
12. Feng N., Burns J. W., Bracy L., Greenberg H. B. Comparison of mucosal and systemic humoral immune responses and subsequent protection in mice orally inoculated with a homologous or a heterologous rotavirus. J. Virol. 68:1994;7766-7773.
13. Franco M. A., Greenberg H. B. Role of B cells and cytotoxic T lymphocytes in clearance of and immunity to rotavirus infection in mice. J. Virol. 69:1995;7800-7806.
14. Ginn D. I., Ward R. L., Hamperian V. V., Hughes J. H. Inhibition of rotavirus in vitro transcription by optimal concentrations of monoclonal antibodies specific for rotavirus VP6. J. Gen. Virol. 73:1992;3017-3022.
15. Groene W. S., Shaw R. D. Psoralen preparation of antigenically intact noninfectious rotavirus particles. J. Virol. Methods. 38:1992;93-102.
16. Hancock G. E., Speelman D. J., Frenchick P. J., Mineo-Kuhn M. M., Baggs R. B., Hahn D. J. Formulation of the purified fusion protein of respiratory syncytial virus with the sapoin QS-21 induces protective immune responses in BALB/c mice that are similar to those generated by experimental infection. Vaccine. 13:1995;391-400.
17. Hancock G. E., Speelman D. J., Heers K., Bortell E., Smith J., Cosco C. Generation of atypical pulmonary inflammatory responses in BALB/c mice after immunization with the native attachment (G) glycoprotein of respiratory syncytial virus. J. Virol. 70:1996;7783-7791.
18. Karagouni E. E., Hadjipetrou-Kourounakis L. Regulation of isotype immunoglobulin production by adjuvants in vivo. Scand. J. Immunol. 31:1990;745-754.
19. Kensil C. R., Patel U., Lennick M., Marciani D. Separation and characterization of saponins with adjuvant activity fromQuillaja saponaria. J. Immunol. 146:1991;431-437.
20. Kensil C. R. Saponins as vaccine adjuvants. Crit. Rev. Therap. Drug Carrier Sys. 13:1996;1-55.
21. Knowlton D. R., Spector D. M., Ward R. L. Development of an improved method for measuring neutralizing antibody to rotavirus. J. Virol. Methods. 33:1991;127-134.
22. Lanata C. F., Midthun K., Black R. E., Butron B., Huapaya A., Penny M. E., Ventura G., Gil A., Jett-Goheen M., Davidson B. L. Safety, immunogenicity, and protective efficacy of one and three doses of the tetravalent rhesus rotavirus vaccine in infants in Lima, Peru. J. Infect. Dis. 174:1996;268-275.
23. Livingston P. O., Adluri S., Helling F., Yao T.-J., Kensil C. R., Newman M. J., Marciani D. Phase 1 trial of immunological adjuvant QS-21 with a GM2 ganglioside-keyhole limpet haemocyanin conjugate vaccine in patients with malignant melanoma. Vaccine. 12:1994;1275-1280.
24. +. Eur. J. Immunol. 25:1995;2835-2841.
25. McNeal M. M., Sheridan J. F., Ward R. L. Active protection against rotavirus infection of mice following intraperitoneal immunization. Virology. 191:1992;150-157.
26. McNeal M. M., Broome R. L., Ward R. L. Active immunity against rotavirus infection in mice is correlated with viral replication and titers of serum rotavirus IgA following vaccination. Virology. 204:1994;642-650.
27. McNeal M. M., Barone K. S., Rae M. N., Ward R. L. Effector functions of antibody and CD8+ cells in resolution of rotavirus infection and protection against reinfection in mice. Virology. 214:1995;387-397.
28. McNeal M. M., Ward R. L. Long-term production of rotavirus antibody and protection against reinfection following a single infection of neonatal mice with murine rotavirus. Virology. 211:1995;474-480.
29. +. J. Immunol. 148:1992;2357-2362.
30. O'Neal C. M., Crawford S. E., Estes M. K., Conner M. E. Rotavirus virus-like particles administered mucosally induce protective immunity. J. Virol. 71:1997;8707-8717.
31. Offit P. A., Clark H. F. Protection against rotavirus-induced gastroenteritis in a murine model by passively acquired gastrointestinal but not circulating antibodies. J. Virol. 54:1985;58-64.
32. Rennels M. B., Glass R. I., Dennehy P. H., Bernstein D. I., Pichichero M. E., Zito E. T., Mack M. E., Davidson B. L., Kapikian A. Z. Safety and efficacy of high-dose rhesus-human reassortant rotavirus vaccines - Report of the National Multicenter Trial. Pediatrics. 97:1996;7-13.
33. Sabara M., Babiuk L. A., Gilchrist J., Misra V. Biochemical evidence for the oligomeric arrangement of bovine rotavirus nucleocapsid protein and its possible significance in the immunogenicity of this protein. J. Gen. Virol. 68:1987;123-133.
34. Santosham M., Letson G. W., Wolfe M., Reid R., Gahagan S., Adams R., Callahan C., Sack R. B., Kapikian A. Z. A field study of the safety and efficacy of two candidate rotavirus vaccines in a Native American population. J. Infect. Dis. 163:1991;483-487.
35. Snodgrass D. R., Campbell I., Mwenda J. M., Chege G., Suleman M. A., Morein B., Hart C. A. Stimulation of rotavirus IgA, IgG and neutralizing antibodies in baboon milk by parenteral vaccination. Vaccine. 13:1995;408-413.
36. Snodgrass D. R., Wells P. W. Rotavirus infection in lambs: studies on passive protection. Arch. Virol. 52:1976;201-205.
37. Thapar M. A., Parr E. L., Bozzola J. J., Parr M. B. Secretory immune responses in the mouse vagina after parenteral or intravaginal immunization with an immunostimulating complex (ISCOM). Vaccine. 9:1991;129-133.
38. Valensi J. M., Carlson J. R., Van Nest G. A. Systemic cytokine profiles in BALB/c mice immunized with trivalent influenza vaccine containing MF59 oil emulsion and other advanced adjuvants. J. Immunol. 153:1994;4029-4039.
39. Ward R. L., McNeal M. M., Sheridan J. F. Development of an adult mouse model for studies on protection against rotavirus. J. Virol. 64:1990;5070-5075.
40. Ward R. L., McNeal M. M., Sheridan J. F. Evidence that active protection following oral immunization of mice with live rotavirus is not dependent on neutralizing antibody. Virology. 188:1992;57-66.